Considerations for drug trials in hypertrophic cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Personal HealthCare of Things: A novel paradigm and futuristic approach
CAAI Transactions on Intelligence Technology, EarlyView., 2023 Abstract This study provides an investigative approach and offers a complete review of research on Internet of Medical Things (IoMT), describing the progress in general and highlighting the research issues, trends, and future aspects of IoMT. Exploring a research strategy for IoMT systems is vital as the need for IoT in healthcare grows. By aggregating
Surbhi Gupta +5 more
wiley +1 more source
Psychopathology associated with cardiac pacing in Tanzania: A case series. [PDF]
SAGE Open Med Case Rep, 2023 Pallangyo P +6 more
europepmc +1 more source
The effects of an angiotensin‐converting inhibitor (enalapril) on patients with mild cardiac failure—evaluating cardiac function based on the relationship between daily walking pace and heart rate [PDF]
, 1998 Eji Ino‐Oka +6 more
openalex +1 more source
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction
ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi +9 more
wiley +1 more source
Refurbishing Pacemakers: A Viable Approach [PDF]
, 2004 Cardiologists implant permanent pacemakers widely for indications like sick sinus syndrome and complete heart block. The guidelines for such implantations are well established1.
J, Balachander, R, Anilkumar
core +1 more source
A phenomap of TTR amyloidosis to aid diagnostic screening
ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos +4 more
wiley +1 more source
Predicting and Recognizing Drug‐Induced Type I Brugada Pattern Using ECG‐Based Deep Learning
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Brugada syndrome (BrS) has been associated with sudden cardiac death in otherwise healthy subjects, and drug‐induced BrS accounts for 55% to 70% of all patients with BrS.
Paul‐Adrian Călburean +19 more
doaj +1 more source
Osborn Waves: History and Significance [PDF]
, 2004 The Osborn wave is a deflection with a dome or hump configuration occurring at the R-ST junction (J point) on the ECG (Fig. 1). In the historical view, different names have been used for this wave in the medical literature, such as “camel-hump sign ...
Atarashi, Hirotsugu +6 more
core +2 more sources